AI Structured Summary
Not yet generated for this judgment
Judgment
Month,"Demand
projected by
Cipla    Â
   to Roche","Quantity
confirmed by
Roche against
that demand","Orders
placed  Â
by Cipla
against
Confirmed
quantity","SuppliesÂ
made         Â
by Roche against
the        Â
order placed
January,
2021",2500,2500,2500,2500
February,
2021",2500,2500,2500,2500
March
2021","42,400","12,350","12,350","12,350
April
2021","1,20,000","11,000","11,000","11,000
May
2021","40,000","10,000","10,000","10,000 (expected in Mid
May)
400 MG, with the Drug Controller General of India, under the Drugs and Cosmetics Act, 1940. The said affidavit to comprehensively specify the",,,,
status/ stage of the said applications as well, if any. Let the affidavit of UOI be also filed by 12th May, 2021 through email to the Court Master.",,,,
Mr. Sameer Kumar Swarup, the Deputy Controller of Patents, has joined the proceedings. Let a status report be filed by him, in respect of the",,,,
details of the patents stated to be covering Tocilizumab 400 MG, as also the working statements in respect thereof, including the date of filing, the term",,,,
of patent etc., The same be also emailed by 12th May, 2021 through email to the Court Master.",,,,
Insofar as the doses which are currently being received by tonight and by 15th May 2021, are concerned, the Union of India as also the GNCTD",,,,
shall take immediate steps to ensure that the same are allocated to States/UTs and distributed transparently, efficiently and in a timely manner, so that",,,,
they can be immediately administered to patients who are in need and have been duly prescribed with the same.,,,,
List for further hearing on 13th May, 2021, at 2:30 PM.",,,,